A Novel Vascular Modulator, Hepatocyte Growth Factor (HGF), as a Potential Index of the Severity of Hypertension

Shigefumi Nakamura(The University of Osaka), Toshio Ogihara(Osaka University), Ryuichi Morishita(The University of Osaka), Yoshikage Yo(The University of Osaka), Motokuni Aoki(Osaka City University), Toshikazu Nakamura(The University of Osaka), Shinichiro Hayashi(The University of Osaka), Nobuaki Nakano, Atsushi Moriguchi(The University of Osaka), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Seiju Takami(Sakurabashi Watanabe Hospital), Tomohiro Katsuya(Japan Medical Association), S. Nakata(The University of Osaka), Kunio Matsumoto(Kanazawa University)
Biochemical and Biophysical Research Communications
January 1, 1998
10.1006/bbrc.1997.7800
Cited by 70

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588